WO2009118758A3 - Novel crystalline forms of desvenlafaxine succinate - Google Patents

Novel crystalline forms of desvenlafaxine succinate Download PDF

Info

Publication number
WO2009118758A3
WO2009118758A3 PCT/IN2009/000191 IN2009000191W WO2009118758A3 WO 2009118758 A3 WO2009118758 A3 WO 2009118758A3 IN 2009000191 W IN2009000191 W IN 2009000191W WO 2009118758 A3 WO2009118758 A3 WO 2009118758A3
Authority
WO
WIPO (PCT)
Prior art keywords
crystalline forms
novel crystalline
desvenlafaxine succinate
succinate
desvenlafaxine
Prior art date
Application number
PCT/IN2009/000191
Other languages
French (fr)
Other versions
WO2009118758A2 (en
Inventor
Rajamannar Thennati
Rajeev Budhdev Rehani
Nischalkumar Vinodbhai Patel
Riteshkumar Rajnikant Kansara
Original Assignee
Sun Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd. filed Critical Sun Pharmaceutical Industries Ltd.
Publication of WO2009118758A2 publication Critical patent/WO2009118758A2/en
Publication of WO2009118758A3 publication Critical patent/WO2009118758A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

Crystalline Form V of O-desmethylvenlafaxine succinate, wherein the crystalline form exhibits an X-Ray Powder Diffraction pattern having characteristic peaks expressed in degrees 2θ ( ±0.2° 2θ ) at 12.15, 13.17, 14.67, 15.8, 19.69, 20.45, 22.27, 24.40, 26.43, 28.44 and 33.69.
PCT/IN2009/000191 2008-03-24 2009-03-23 Novel crystalline forms of desvenlafaxine succinate WO2009118758A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN175MU2008 2008-03-24
IN175/MUM/2008 2008-03-24
IN617/MUM/2008 2008-03-24
IN617MU2008 2008-03-24

Publications (2)

Publication Number Publication Date
WO2009118758A2 WO2009118758A2 (en) 2009-10-01
WO2009118758A3 true WO2009118758A3 (en) 2011-05-26

Family

ID=41114416

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000191 WO2009118758A2 (en) 2008-03-24 2009-03-23 Novel crystalline forms of desvenlafaxine succinate

Country Status (1)

Country Link
WO (1) WO2009118758A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933123B2 (en) 2010-10-08 2015-01-13 Cadila Healthcare Limited Polymorphic forms of O-desmethyl-venlafaxine succinate

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064543A2 (en) * 2001-02-12 2002-08-22 Wyeth Novel succinate salt of o-desmethyl-venlafaxine
WO2008156748A2 (en) * 2007-06-15 2008-12-24 Teva Pharmaceutical Industries Ltd. Crystal forms of o-desmethylvenlafaxine succinate
WO2009009665A2 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
WO2009010990A2 (en) * 2007-07-16 2009-01-22 Matrix Laboratories Limited Process for the preparation of o-desmethylvenlafaxine succinate polymorphic forms
US20090246284A1 (en) * 2008-04-01 2009-10-01 Actavis Group Ptc Ehf O-desmethylvenlafaxine Cocrystals

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064543A2 (en) * 2001-02-12 2002-08-22 Wyeth Novel succinate salt of o-desmethyl-venlafaxine
WO2008156748A2 (en) * 2007-06-15 2008-12-24 Teva Pharmaceutical Industries Ltd. Crystal forms of o-desmethylvenlafaxine succinate
WO2009009665A2 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
WO2009010990A2 (en) * 2007-07-16 2009-01-22 Matrix Laboratories Limited Process for the preparation of o-desmethylvenlafaxine succinate polymorphic forms
US20090246284A1 (en) * 2008-04-01 2009-10-01 Actavis Group Ptc Ehf O-desmethylvenlafaxine Cocrystals

Also Published As

Publication number Publication date
WO2009118758A2 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
IL260158B (en) Pyrazine derivatives, compositions comprising the same and uses thereof
EP2166058B8 (en) Friction material composition, and friction material produced therewith
AU2006227151B2 (en) Coating composition with solar properties
IL205057A0 (en) Pyrimidyl indoline compound, composition comprising the same and uses thereof
WO2007047084A3 (en) Thermally exfoliated graphite oxide
WO2009120182A3 (en) Sulfo-polymer powder and sulfo-polymer powder blends with carriers and/or actives
EP1932889A4 (en) Pearlescent pigment, process for producing the same, coating material composition and coating film composition
EP2226142A4 (en) Powder and method for producing the same
IL201158A0 (en) Soild forms of pemetrexed , compositions comprising the same and processes for the preparation thereof
EP2165694B8 (en) Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle
IL201064A0 (en) Janus kinase inhibitor compounds, compositions comprising the same and uses thereof
PL2155824T3 (en) Pigment preparation, method for producing the same and its use
EP2174999A4 (en) Thermal-flowability regulator for powder coating composition, process for producing the same, and powder coating composition
TWI369360B (en) Tantalum compound, method for producing the same, tantalum-containing thin film, and method for forming the same
EP2088140A4 (en) Dihydrazide compounds, preparation and uses thereof
EP1905099A4 (en) Diffraction foils
EP2177490A4 (en) Ceramic substrate, process for producing the same, and dielectric-porcelain composition
EP2138547A4 (en) Resin composition for aqueous coating material, method for producing the same, and aqueous coating material
USD607924S1 (en) Typeface
WO2009025792A3 (en) Crystalline forms cinacalcet fumarate and cinacalcet succinate and processes for preparation thereof
ZA201000520B (en) Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
WO2008081041A3 (en) Amorphous and crystalline forms of rivastigmine hydrogentartrate
WO2009118758A3 (en) Novel crystalline forms of desvenlafaxine succinate
WO2009002489A3 (en) Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin
EP1911739A3 (en) Crystalline form of (S)-2-phenylethylammonium (R)-diphenyl-methanesulphinyl-acetate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09724274

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09724274

Country of ref document: EP

Kind code of ref document: A2